Efficacy and Safety of Rimegepant in Patients with Migraine Receiving CGRP mAb Preventive Treatment
Case Study: Our research site embarked on a pioneering clinical trial to explore the safety, tolerability, and efficacy of oral rimegepant for acute migraine treatment among patients concurrently receiving calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) for preventive treatment. This study aimed to fill a crucial gap in migraine management by assessing the compatibility and …